MedLeanRx review

What it is

MedLeanRx describes itself as a physician-guided online weight-loss platform for patients in Texas, with an address on Sawdust Road in Spring, outside Houston. It says it was founded by a team of physicians and names Dr. Johnson Uzor, M.D., as its supervising physician. Its terms say it connects patients with licensed providers rather than practicing medicine itself, and that Texas law governs. Besides weight loss, it runs a testosterone therapy program for men and a sexual wellness program. It's direct-pay only and doesn't bill insurance, though it says you may be able to submit receipts for reimbursement. Support is by email and through a contact form, weekdays 9 a.m. to 6 p.m. and Saturdays 10 a.m. to 2 p.m. Central time.

How it works

You complete an online health assessment the site says takes under five minutes; no appointment is needed. A licensed physician reviews your history, BMI and goals, with a target turnaround of under 12 hours. Its FAQ gives the usual eligibility guide: a BMI of 30 or more, or 27 or more with a weight-related condition, and age 18 or over. If you're approved, medication ships in temperature-controlled packaging within two to three business days, and most patients have it within five to seven business days of the assessment. After that, the physician follows up to track progress, adjust your dose and manage side effects. The promotions page works differently: you pay first, then schedule a consultation with a doctor.

Pricing transparency

The products page lists compounded semaglutide vials at $149 a month, compounded semaglutide tablets at $149 a month and compounded tirzepatide injections at $269 a month. A footnote says plans start at $149 for the starting dose and that pricing can vary by medication and dose, so the cost at maintenance doses isn't shown. For brand-name Wegovy injections, the Wegovy pill, Zepbound and Foundayo, MedLeanRx charges $99 a month for its care, and you pay for the medication separately. A promotions page offers two months of compounded tirzepatide at 2 mg a week for $325 or two months of compounded semaglutide for $300, while supplies last. The FAQ says there are no long-term contracts or cancellation fees and you can cancel any time. The terms add that all sales are final and that consultations, provider reviews, subscription fees and other fees are not refunded, and payment doesn't guarantee a prescription.

Branded vs compounded

MedLeanRx offers compounded semaglutide as a weekly injection or a daily tablet, compounded tirzepatide as a weekly injection, and brand-name Wegovy (pen or pill), Zepbound and Foundayo (orforglipron), the last three managed for a monthly fee with the drug bought separately. Its terms and promotions state that compounded medications are not FDA-approved and haven't been reviewed for quality, safety or efficacy. Its homepage blurs that line, describing the whole program as offering "FDA-approved" treatments and calling compounded semaglutide "the same active ingredient found in Wegovy", and the weight-loss estimates it shows come from trials of the brand-name drugs. The pharmacy isn't named. Its footer links to LegitScript's search page rather than a numbered certification. A search of the FDA warning-letter database under the company's name and web address returned no letters.

Pros and watch-outs

The evidence behind what MedLeanRx prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• What the semaglutide weight-loss trials actually showed

  STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.

• Tirzepatide vs semaglutide for weight loss: what the trials actually support

  Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.

• Compounded vs branded GLP-1: regulatory status, sourcing and the evidence

  Compounded GLP-1 isn't FDA-approved, the shortage exception behind it ended in 2025, the FDA moved against mass-marketed copies in 2026, and the trial data belong to the branded product. Here's the precise picture.

• Orforglipron: the oral non-peptide GLP-1, and what the trials actually show

  A once-daily small-molecule GLP-1 pill with no food restrictions — from Phase 2 proof of concept to the Phase 3 read-outs. The evidence, graded.

How MedLeanRx compares

A few alternatives worth a look, depending on what you’re optimizing for.

• MadeMed

  GLP-1 paired with NAD⁺ and sermorelin under one account

  See MadeMed →
• Shed

  A wide range of GLP-1 formats (injection, drops, lozenges, microdose)

  See Shed →
• Henry Meds

  Simple flat-fee compounded access without insurance

  See Henry Meds →

More GLP-1 telehealth reviews: EverFit Medical · Evergreen Telehealth · Evernow · Factor Health MD · Fidelity Medical Clinic · Good Girl Rx